1. Home
  2. TS vs KVUE Comparison

TS vs KVUE Comparison

Compare TS & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenaris S.A.

TS

Tenaris S.A.

SELL

Current Price

$59.42

Market Cap

28.9B

Sector

Industrials

ML Signal

SELL

Logo Kenvue Inc.

KVUE

Kenvue Inc.

SELL

Current Price

$18.82

Market Cap

34.2B

ML Signal

SELL

Company Overview

Basic Information
Metric
TS
KVUE
Founded
2001
2022
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Specialty Chemicals
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
28.9B
34.2B
IPO Year
2002
2023

Fundamental Metrics

Financial Performance
Metric
TS
KVUE
Price
$59.42
$18.82
Analyst Decision
Buy
Hold
Analyst Count
12
14
Target Price
★ $64.96
$19.50
AVG Volume (30 Days)
1.0M
★ 17.3M
Earning Date
11-04-2026
11-02-2026
Dividend Yield
4.16%
★ 4.50%
EPS Growth
N/A
★ 40.74
EPS
N/A
★ 0.48
Revenue
N/A
★ $15,124,000,000.00
Revenue This Year
$2.03
$3.12
Revenue Next Year
$6.66
$2.38
P/E Ratio
★ $12.59
$38.85
Revenue Growth
★ N/A
N/A
52 Week Low
$34.31
$14.02
52 Week High
$64.60
$20.13

Technical Indicators

Market Signals
Indicator
TS
KVUE
Relative Strength Index (RSI) 60.96 65.59
Support Level $57.16 $18.67
Resistance Level $60.64 $19.15
Average True Range (ATR) 1.16 0.27
MACD 0.24 0.17
Stochastic Oscillator 98.16 91.52

Price Performance

Historical Comparison
TS
KVUE

About TS Tenaris S.A.

Tenaris SA is engaged in the manufacture and supply of steel pipe products and related services for the energy industry and other industrial applications. The company has one reportable segment, Tubes, which includes the production and sale of steel tubular products such as OCTG, line pipe, and mechanical and structural tubes, mainly for the oil and gas industry. It operates an integrated network of manufacturing, research, and service facilities across the Americas, Europe, the Middle East, Asia, and Africa.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.

Share on Social Networks: